Cuts May Curb Generic Use: APhA

Published Online: Wednesday, February 1, 2006

The new pharmacist reimbursement formula established under the Medicaid program cuts passed by Congress late last year may result in reduced generic substitution by the nation's pharmacies, officials at the American Pharmacists Association (APhA) warned.

The controversial budget cuts "will likely have a disastrous impact on the profession's ability to provide necessary care to Medicaid patients,"APhA said in response to the legislation.

At the same time, however, the association suggested that the cutback may prove to be counterproductive by discouraging pharmacists from dispensing more cost-effective generic medicines. According to APhA, "the new payment formula, through an absence of incentives, could actually discourage the dispensing of generic drugs, a significant source of Medicaid savings."

Latest Articles
Pharmacies are rated as some of the best places to receive top-notch customer service in America.
Often caused by acid reflux, eosinophilic esophagitis is an emerging inflammatory disease that is generally unresponsive to proton pump inhibitor therapy.
Carlos Aquino, founder and president of PharmaDiversion LLC, discusses timing of inspections from the Drug Enforcement Administration.
The FDA has again rejected AMAG Pharmaceuticals’ application for a single-dose version of hydroxyprogesterone caproate injection (Makena) to reduce the risk of preterm birth for at-risk women.
Latest Issues